Cellular and proteomic differences associated with lithium response in olfactory neuroepithelium cells of bipolar disorder patients

Background Lithium is a first-line treatment for bipolar disorder (BD), but only 30% of patients respond satisfactorily to monotherapy, and the biological basis for this variability remains unclear. This study aimed to identify potential biomarkers and therapeutic targets by analyzing olfactory neur...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Molecular medicine (Cambridge, Mass.) Jg. 31; H. 1; S. 294 - 17
Hauptverfasser:	Hidalgo-Figueroa, Maria, Delgado-Sequera, Alejandra, Pérez-Ramos, Anaid, Durán-Ruiz, MªCarmen, Romero-Lopez-Alberca, Cristina, Pérez-Revuelta, Jose I., Marquez-Estefenn, Ingrid, García-Mompó, Clara, Moreno, Jose Ma Villagrán, Berrocoso, Esther
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 26.09.2025 BMC
Schlagworte:	Adult Biomarkers Biomedical and Life Sciences Biomedicine Bipolar disorder Bipolar Disorder - drug therapy Bipolar Disorder - metabolism Bipolar Disorder - pathology Cell Adhesion - drug effects Cytoskeleton Epithelial Cells - drug effects Epithelial Cells - metabolism Female Humans Lithium Lithium - pharmacology Lithium - therapeutic use Male Middle Aged Molecular Medicine Olfactory Mucosa - drug effects Olfactory Mucosa - metabolism Olfactory Mucosa - pathology Olfactory neuroepithelium Proteome Proteomics Proteomics - methods Bipolar disorder Cytoskeleton Lithium Olfactory neuroepithelium Proteomics
ISSN:	1528-3658, 1528-3658
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!